Foquest is now covered on the Nova Scotia Formulary

Effective Dec 1, 2023, Foquest is listed on the Nova Scotia Formulary for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as an Exception Status Benefit.

Learn more about the eligibility criteria for reimbursement of Foquest in Nova Scotia.

The website is hand-crafted in ZippyHippo online marketing studio.